About Saprogal
Saprogal is a company based in Vila Real (Portugal) founded in 1991, and was acquired by De Heus in November 2015. Pediatric pharmaceuticals and related medical devices are manufactured.
Company details
Saprogal was founded in 1991 in Vila Real, Portugal, within the pharmaceutical sector focused on child health. Medications tailored for common childhood illnesses are developed and produced, alongside medical devices that support pediatric care. Operations are conducted across multiple facilities equipped with advanced automation. Stringent quality control standards are applied throughout the research, development, and manufacturing processes to ensure product safety and efficacy.
- Headquarters Vila Real, Portugal
- Stage Acquired
- Email••••••••
- Website saprogal.pt
- Social LinkedIn
- Acquired by De Heus (Nov 2015)
Funding Insights of Saprogal
- Total Rounds 1
- Investors Count 3
All 1 funding rounds of Saprogal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2010 | Series B | – | – |
4 investors in total: 4 institutional.
Investors in Saprogal
Saprogal has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Alantra, pascual and De Heus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity capital is invested in small and mid-sized businesses. | higcapital.com | Miami, United States | ||
Multi-category beverages are manufactured and branded by Pascual. | 1969 | calidadpascual.com | ||
Global mid-market investment banking services are provided across sectors. | 2001 | alantra.com | London, United Kingdom | |
Provider of animal feed and nutritional solutions for livestock and aquaculture | 1911 | deheus.com | Ede, Netherlands |
Investor details for Saprogal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Saprogal
3 dated milestones of Saprogal across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Saprogal is founded.
- Funding First funding round.
- Exit Acquired by De Heus.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Saprogal
Saprogal was founded in 1991 and raised its 1st funding round 19 years after it was founded.
Saprogal is headquartered in Vila Real, Portugal. It is registered at Vila Real, Vila Real, Portugal.
Saprogal was founded in 1991 in Vila Real, Portugal, within the pharmaceutical sector focused on child health. Medications tailored for common childhood illnesses are developed and produced, alongside medical devices that support pediatric care. Operations are conducted across multiple facilities equipped with advanced automation. Stringent quality control standards are applied throughout the research, development, and manufacturing processes to ensure product safety and efficacy.
Saprogal has 4 investors. Key investors include Alantra, pascual, De Heus, and H.I.G. Capital.
Yes. Saprogal was acquired by De Heus in November 2015.